Neural Cell News 14.04 February 5, 2020 | |
| |
TOP STORYMicroglia Monitor and Protect Neuronal Function through Specialized Somatic Purinergic Junctions Scientists identified an interaction site between neuronal cell bodies and microglial processes in mouse and human brain. Somatic microglia-neuron junctions have a specialized nanoarchitecture optimized for purinergic signaling. [Science] Abstract | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)The crosstalk activation of epidermal growth factor receptor (EGFR) and mesenchymal-epithelial transition factor (MET) signaling pathways was demonstrated to contribute to temozolomide resistance, resulting in an unfavorable prognosis for patients with glioblastoma. [Nat Commun] Full Article Fibrinogen inhibited neuronal differentiation in subventricular zone and hippocampal neural stem/progenitor cells while promoting astrogenesis via activation of the BMP receptor signaling pathway. [Nat Commun] Full Article The pathway of absent in melanoma 2 (AIM2) inflammasome-mediated pyroptosis, the AIM2/Caspase-1/gasdermin D(GSDMD) pathway, was explored after experimental subarachnoid hemorrhage in vivo and in primary cortical neurons stimulated by oxyhemoglobin in vitro. [Cell Death Dis] Full Article Researchers confirmed that lncRNA brain-derived neurotrophic factor antisense (BDNF-AS) was downregulated in glioblastoma tissues and cells, interacted and stabilized by polyadenylate-binding protein cytoplasmic 1 (PABPC1). [Cell Death Dis] Full Article Adult Human Glioblastomas Harbor Radial Glia-Like Cells Single-cell RNA sequencing analyses of glioblastoma cells revealed transcriptionally dynamic clusters of radial glia-like cells that shared the profiles of normal human fetal radial glia and that resided in quiescent and cycling states. [Stem Cell Reports] Full Article Comparative Cytotoxicity of Inorganic Arsenite and Methylarsenite in Human Brain Cells The authors assessed the toxicity in different types of brain cells exposed to either inorganic trivalent arsenic or methylarsenite using both morphological and cytotoxicity cell-based analysis. [ACS Chem Neurosci] Abstract Chondroitin Sulfate Synthase 1 Enhances Proliferation of Glioblastoma by Modulating PDGFRA Stability Scientists showed that the expression of CHSY1 was significantly associated with chondroitin sulfate formation in glioma tissue and cells. In addition, overexpression of CHSY1 in glioma cells enhanced cell viability and orthotopic tumor growth, whereas CHSY1 silencing suppressed malignant growth. [Oncogenesis] Full Article Investigators examined Nox2-derived reactive oxygen species in mediating microglial response to amyloid-β peptide 1-42 stimulation in vitro, in aging-associated microgliosis in vivo and in post-mortem human samples. [Sci Rep] Full Article NFкB Is a Critical Transcriptional Regulator of Atypical Cadherin FAT1 in Glioma Characterization of FAT1 promoter for transcriptional regulation was performed by in vitro functional assays using promoter deletion constructs, site directed mutagenesis and ChIP in glioblastoma cells. [BMC Cancer] Full Article Subscribe to one of our other 19 science newsletters such as Cancer Stem Cell News & ESC & iPSC News. | |
| |
REVIEWSReevaluating the Role of Persistent Neural Activity in Short-Term Memory The authors discuss how the neural mechanisms underlying short-term memory are inextricably linked with the cognitive demands of the task, such that the passive maintenance and the active manipulation of information are subserved differently in the brain. [Trends Cogn Sci] Abstract Microglia Heterogeneity in the Single-Cell Era The authors summarize the current knowledge about the spatial, temporal, and functional diversity of microglia during development, homeostasis, and disease in mice and humans. [Cell Rep] Abstract Visit our reviews page to see a complete list of reviews in the neural cell research field. | |
| |
INDUSTRY NEWSAlkahest, Inc. announced the dosing of the first patient in a Phase II clinical trial of AKST4290, an orally administered CCR3 inhibitor, for treatment of Parkinson’s disease. [Alkahest, Inc.] Press Release VistaGen Therapeutics announced that its Investigational New Drug Application for AV-101, the company’s oral NMDAR glycine site antagonist, as a potential treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy has been cleared by the FDA. [VistaGen Therapeutics, Inc.] Press Release | |
| |
POLICY NEWSWhy Did a Chinese University Hire Charles Lieber to Do Battery Research? Among the ongoing mysteries surrounding last week’s arrest of Harvard University nanoscientist Charles Lieber is the precise nature of the research program Lieber was conducting in his cooperation with Chinese researchers. [ScienceInsider] Editorial US Prosecutor Leading China Probe Explains Effort That Led to Charges against Harvard Chemist The US government isn’t prosecuting Charles Lieber because he’s a world-renowned inorganic chemist at Harvard University, says the US attorney who last week drew headlines by charging Lieber with making false statements about his ties to Chinese research institutions. Nor does the Department of Justice think for one minute that Lieber is a spy. [ScienceInsider] Editorial Cash from Cannabis Companies Creates Conflicted Researchers Imagine that scientists charged with doing research on tobacco’s health implications were funded by tobacco companies. In fact, the tobacco industry used this tactic for decades to cast doubt on the adverse health effects of smoking. But today it would be an outrageous conflict of interest – research on addictive drugs shouldn’t be paid for by people who stand to profit from selling them. Yet this is exactly what is happening with cannabis. [STAT News] Editorial
| |
EVENTSNEW 2nd Neuroepigenetics and Neuroepitranscriptomics Conference Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Postdoctoral Fellow – Translational Brain Tumor Research (Northwestern University) NEW Branch Chief – Neuroscience Research (National Institutes of Health) Bioinformatician Positions – Molecular Neurobiology (Karolinska Institutet) Faculty Position – Neuroimmunology (St. Jude Children’s Research Hospital) Postdoctoral Fellow – Vascular Dysfunction in Neurodegeneration (Translational Neurology Group) Postdoctoral Researcher – Neurodegenerative Diseases and Cancer (University of Pennsylvania) Research Cognitive Neurologist (University Health Network) Postdoctoral Associate – Glia and Neuron Interaction (Howard Hughes Medical Institute) Multiple Faculty Positions – Neuroscience and Neuroengineering (Tsinghua University) Faculty Positions – Brain Disorders (IDG/McGovern Institute for Brain Research) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Neural Cell News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|